Late outcome after surgical and topical treatment for Aspergillus mediastinitis after heart transplantation
暂无分享,去创建一个
P. Mohacsi | P. Vogt | M. Flepp | Raed Aser | C. Mestres | P. Berdat | D. Schmidlin | P. Went
[1] R. Jain,et al. Use of Topical Colistin in Multiple Drug-Resistant Pseudomonas aeruginosa Bacterial Keratitis , 2014, Cornea.
[2] F. Ruschitzka,et al. Fatal outcome after heart transplantation caused by Aspergillus lentulus , 2012, Transplant infectious disease : an official journal of the Transplantation Society.
[3] A. Erbay,et al. Pan-resistant Acinetobacter baumannii mediastinitis treated successfully with tigecycline: a case report. , 2011, Surgical infections.
[4] S. Chu,et al. Surgical treatment of mediastinitis after cardiac transplantation. , 2008, Transplantation proceedings.
[5] S. Miyakis,et al. Acinetobacter baumannii mediastinitis after cardiopulmonary bypass: case report and literature review. , 2008, Surgical infections.
[6] Raoul Herbrecht,et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] U. Jurkunas,et al. Use of Voriconazole in the Treatment of Fungal Keratitis , 2007, International ophthalmology clinics.
[8] W. Haefeli,et al. Voriconazole Concentration in Human Aqueous Humor and Plasma during Topical or Combined Topical and Systemic Administration for Fungal Keratitis , 2006, Antimicrobial Agents and Chemotherapy.
[9] L. Gopal,et al. INTRAVITREAL VORICONAZOLE FOR DRUG-RESISTANT FUNGAL ENDOPHTHALMITIS: Case Series , 2006, Retina.
[10] A. Khaghani,et al. Acinetobacter mediastinitis in a heart transplant patient. , 2006, The Annals of thoracic surgery.
[11] R. Grillot,et al. In vitro testing of fungicidal activity of biocides against Aspergillus fumigatus. , 2005, Journal of medical microbiology.
[12] D. Christmann,et al. A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole , 2005, European Journal of Clinical Microbiology and Infectious Diseases.
[13] Nina Singh,et al. Aspergillus Infections in Transplant Recipients , 2005, Clinical Microbiology Reviews.
[14] B. Suh,et al. Aspergillus mediastinitis following orthotopic heart transplantation: case report and review of the literature , 2004, Transplant infectious disease : an official journal of the Transplantation Society.
[15] C. A. Kauffman,et al. Voriconazole: a new triazole antifungal agent. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] N. Smedira,et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants , 2002, Transplant infectious disease : an official journal of the Transplantation Society.
[17] Richard Sylvester,et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. , 2002, The New England journal of medicine.
[18] G. Johnson,et al. Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh , 1998, The British journal of ophthalmology.
[19] N. Mozzillo,et al. [Chlorhexidine gluconate in the treatment of subphrenic abscess and thoracic empyema]. , 1987, Minerva chirurgica.